immunolog
checkpoint
inhibitori
receptor
play
dual
role
balanc
immun
system
microbi
infect
one
hand
inhibitori
signal
prevent
excess
immun
mediat
patholog
hand
may
impair
clearanc
pathogen
studi
influenc
inhibitori
axi
clearanc
patholog
two
differ
viru
infect
model
find
lack
signal
strongli
enhanc
type
interferon
ifn
product
viral
clearanc
improv
outcom
mous
hepat
corona
viru
mhv
infect
particularli
femal
mice
mhv
clearanc
known
depend
toll
like
receptor
mediat
type
ifn
product
sex
differ
respons
previous
report
human
therefor
hypothes
ligat
suppress
respons
releas
inhibit
enlarg
sex
differ
signal
hypothesi
support
find
vivo
administr
synthet
ligand
lead
enhanc
type
ifn
product
particularli
femal
mice
ligat
inhibit
signal
vitro
influenza
viru
infect
show
viral
clearanc
determin
sex
signal
howev
absenc
influenza
viru
infect
result
enhanc
lung
neutrophil
influx
patholog
femal
thu
sex
host
factor
togeth
determin
outcom
viral
infect
data
predict
sex
bia
benefici
patholog
immun
respons
viru
infect
upon
therapeut
target
gener
appropri
control
respons
infect
immun
system
balanc
action
activ
inhibitori
receptor
lack
inhibit
lead
excess
inflamm
autoimmun
sever
diseas
symptom
one
receptor
regul
balanc
receptor
origin
describ
myeloid
receptor
express
macrophag
granulocyt
dc
later
other
recogn
also
express
cell
b
cell
nk
cell
intracellular
domain
devoid
classic
immunoreceptor
tyrosinebas
inhibit
motif
itim
present
immun
inhibitori
receptor
three
tyrosin
residu
phosphoryl
one
embed
npxi
motif
signal
depend
recruit
rasgap
signal
trigger
result
deliveri
inhibitori
intracellular
signal
cell
given
ligand
short
intracellular
tail
devoid
known
signal
motif
express
thymocyt
activ
cell
b
cell
dendrit
cell
dc
vascular
endotheli
cell
hair
follicular
cell
central
nervou
system
retina
review
mice
human
exclus
bind
inhibitori
contrast
human
mous
famili
contain
sever
activ
receptor
bind
mice
first
describ
suscept
autoimmun
disord
later
role
microbi
infect
recogn
infect
mice
gram
neg
n
meningitid
caus
increas
lethal
proinflammatori
cytokin
product
lymphocyt
activ
other
show
mous
influenza
viru
infect
aggrav
immun
patholog
studi
exclus
perform
femal
mice
indic
signal
control
strength
initi
antimicrobi
respons
return
homeostasi
studi
influenc
blockad
clearanc
patholog
two
differ
viru
infect
model
coronaviru
influenza
viru
male
femal
mice
mous
hepat
coronaviru
mhv
accept
model
illustri
coronaviru
cov
sever
acut
respiratori
syndrom
sar
cov
host
control
mhv
infect
complet
depend
immedi
type
ifn
respons
initi
upon
trigger
viral
rna
mice
lack
pathway
show
massiv
mhv
replic
fatal
infect
within
day
model
strong
antivir
respons
caus
immun
mediat
patholog
studi
influenza
viru
infect
immun
patholog
known
import
clinic
outcom
report
lack
signal
profound
effect
benefici
also
patholog
immun
respons
virus
femal
mice
compar
male
mice
attribut
capac
inhibit
respons
determin
role
signal
cov
infect
intraperiton
inocul
male
femal
wild
type
wt
mice
recombin
mhv
encod
luciferas
mhveflm
monitor
viral
spread
use
bioluminesc
imag
bli
day
infect
interestingli
time
point
observ
decreas
viral
spread
femal
wt
mice
compar
male
moreov
lack
result
significantli
lower
level
viral
replic
femal
figur
b
figur
b
c
viral
rna
load
liver
day
assess
quantit
pcr
confirm
imag
result
wt
femal
mice
significantli
lower
viral
rna
level
wt
male
mice
figur
greatli
decreas
viru
load
femal
mice
confirm
histolog
liver
section
stain
monoclon
antibodi
mhv
data
shown
number
focal
lesion
liver
typic
mhv
also
lower
femal
mice
signific
effect
lesion
femal
mice
figur
e
clearanc
mhv
critic
depend
type
ifn
product
hematopoiet
cell
wt
mice
mhv
infect
result
detect
ifna
product
femal
mice
figur
anim
femal
male
produc
detect
amount
ifna
femal
mice
produc
highest
amount
ifna
figur
ifna
concentr
serum
invers
correl
viral
load
day
p
data
shown
thu
combin
femal
sex
defici
result
increas
type
ifn
product
decreas
viral
load
patholog
upon
mhv
infect
enhanc
respons
femal
mice
sex
differ
respons
previous
report
human
observ
sex
differ
ifna
product
viral
clearanc
upon
mhv
infect
mice
like
due
similar
sex
bia
respons
hypothes
signal
suppress
respons
wt
mice
releas
inhibit
would
reveal
intrins
higher
respons
femal
result
rapid
viral
clearanc
test
hypothesi
first
administ
ligand
vivo
describ
previous
intraperiton
inject
synthet
ligand
imiquimod
lead
rapid
releas
type
ifn
circul
onehour
inject
detect
signific
amount
ifna
sera
femal
mice
confirm
notion
inhibit
intrins
potenti
higher
respons
femal
figur
sacrif
mice
hr
ligand
inject
time
point
serum
ifna
detect
data
shown
type
ifn
mrna
could
detect
liver
mice
femal
express
ifnb
mrna
male
femal
mice
display
even
elev
ifnb
mrna
level
figur
thu
releas
inhibit
lead
increas
product
type
ifn
respons
ligand
particularli
femal
mice
next
test
whether
signal
directli
inhibit
signal
transduc
via
gener
chimer
construct
contain
receptor
intracellular
tail
replac
allow
effici
crosslink
use
antibodi
induc
signal
via
cytoplasm
tail
transfect
hek
cell
plasmid
encod
chimer
receptor
human
luciferas
report
control
nfkb
driven
promot
crosslink
chimer
receptor
antibodi
isotypematch
control
antibodi
result
robust
inhibit
imiquimodinduc
nfkb
activ
figur
contain
three
intracellular
tyrosin
residu
chimer
protein
three
tyrosin
mutat
phenylalanin
fff
suppress
respons
upon
crosslink
indic
observ
inhibitori
effect
inde
depend
figur
cell
line
stabl
ectop
express
transient
express
nfkbreport
construct
also
observ
signal
inhibit
signal
similar
effect
observ
luciferas
express
driven
ifnb
promot
figur
thu
enhanc
type
ifn
product
viral
clearanc
mhv
femal
mice
explain
releas
inhibit
intrins
higher
respons
femal
strong
antivir
respons
also
caus
immun
mediat
patholog
detriment
host
therefor
move
viru
infect
model
immun
patholog
known
immun
respons
need
care
orchestr
prevent
diseas
due
overact
immun
system
immunolog
checkpoint
provid
immun
inhibitori
receptor
set
threshold
activ
dampen
immun
system
case
viral
infect
prevent
patholog
induc
immun
system
hand
may
prevent
adequ
remov
viru
paper
show
remov
immunolog
checkpoint
mice
lead
rapid
remov
corona
viru
also
immuneinduc
diseas
symptom
case
influenza
viru
infect
observ
predominantli
femal
mice
demonstr
particular
checkpoint
inhibit
antivir
respons
natur
stronger
femal
releas
checkpoint
enlarg
sex
differ
find
major
implic
therapeut
use
blocker
pathway
current
clinic
trial
treatment
cancer
predict
femal
patient
stronger
respons
therapeut
import
clinic
outcom
upon
intranas
infect
influenza
viru
observ
sex
bia
viral
load
measur
lung
day
post
infect
figur
femal
mice
lower
viral
load
compar
male
mice
accompani
enhanc
ifna
concentr
bronchoalveolar
lavag
bal
fluid
figur
howev
oppos
mhv
infect
enhanc
type
ifn
product
influenza
viru
infect
figur
confirm
previou
report
found
significantli
enhanc
bodi
weight
loss
femal
mice
compar
wt
femal
figur
although
male
mice
lost
weight
wt
male
weight
loss
start
later
differ
promin
figur
may
indic
lack
result
sever
patholog
femal
observ
increas
level
cellular
infiltr
lung
tissu
femal
figur
therefor
determin
lung
cellular
influx
differenti
cell
count
bal
fluid
figur
total
number
cell
bal
fluid
higher
femal
group
differ
signific
figur
number
lymphocyt
increas
femal
genotyp
figur
day
infect
number
lymphocyt
increas
femal
wt
group
day
number
neutrophil
bal
fluid
decreas
group
still
wt
femal
display
elev
number
male
importantli
lack
result
significantli
higher
neutrophil
count
femal
male
figur
addit
paramet
lung
damag
measur
total
protein
content
bal
fluid
lack
result
increas
protein
level
bal
fluid
male
femal
especi
day
infect
figur
overal
data
indic
femal
mice
experi
increas
lung
patholog
upon
influenza
viru
infect
aggrav
lack
pathway
agreement
increas
neutrophil
count
measur
elev
level
kc
bal
fluid
figur
concentr
increas
femal
day
infect
enhanc
lack
day
figur
tnfa
hardli
detect
significantli
increas
level
measur
femal
mice
day
infect
figur
thu
two
differ
viral
infect
model
conclud
sex
profound
effect
type
ifn
product
viral
clearanc
studi
first
report
significantli
enhanc
viral
clearanc
femal
mice
due
sex
bia
respons
sex
differ
induc
type
ifn
product
previous
report
human
data
show
mice
strong
impact
cours
viral
infect
mechan
understood
one
hand
incomplet
inactiv
gene
x
chromosom
result
higher
express
femal
propos
experi
mrna
express
equal
male
femal
mice
figur
consist
prior
report
evid
escap
xinactiv
gene
human
found
conflict
report
concern
influenc
sex
hormon
respons
altern
sexdepend
epigenet
mechan
may
contribut
demonstr
direct
inhibit
signal
previous
inhibit
lpsinduc
cytokin
product
report
suggest
affect
proxim
event
tlr
signal
pathway
uniqu
inhibitori
receptor
sinc
intracellular
tail
contain
itim
contain
three
intracellular
tyrosin
residu
mutat
three
tyrosin
complet
abrog
inhibitori
function
distal
tyrosin
locat
npxi
motif
adaptor
molecul
recruit
dok
activ
rasgap
knockdown
protein
diminish
inhibitori
action
howev
downstream
target
mediat
inhibit
yet
identifi
upon
influenza
viru
infect
strongli
enhanc
neutrophil
influx
lung
femal
mice
possibl
lead
patholog
affect
viral
clearanc
type
ifn
product
impli
influenza
viru
sexbias
type
ifn
product
viral
clearanc
regul
event
lead
increas
neutrophil
recruit
lung
patholog
neutrophil
respons
influenza
viru
infect
shown
depend
sinc
neutrophil
express
strongli
increas
neutrophil
influx
femal
mice
line
find
inhibit
sexbias
respons
contrast
mhv
infect
clearanc
influenza
viru
depend
plasmacytoid
dendrit
cell
although
influenza
rna
trigger
main
sourc
type
ifn
infect
respiratori
epithelium
cell
express
henc
influenc
explain
lack
effect
type
ifn
product
emerg
evid
tumor
cell
employ
immunolog
checkpoint
benefit
result
inhibitori
immun
pathway
becom
therapeut
target
strengthen
antitumor
respons
develop
adjuv
therapeut
strategi
cancer
treatment
success
applic
cytotox
tlymphocyt
antigen
melanoma
follow
block
agent
checkpoint
among
immun
inhibitori
pathway
strong
evid
role
tumor
progress
come
studi
patient
express
independ
prognost
factor
multipl
myeloma
acut
myeloid
leukemia
predict
wors
overal
surviv
patient
clinic
trial
block
antibodi
aim
enhanc
antitumor
respons
toward
malign
clinicaltrialsgov
identifi
basi
data
one
predict
side
effect
would
sever
immun
patholog
infect
find
combin
lack
signal
femal
sex
profound
impact
control
viru
infect
well
immun
patholog
rais
import
issu
first
demonstr
strong
sex
bia
type
ifn
product
viral
clearanc
mice
util
two
differ
model
viru
infect
import
scientist
studi
wide
use
model
may
result
complet
differ
interpret
data
obtain
depend
sex
mice
use
moreov
sex
bias
clinic
respons
viru
infect
report
human
influenza
viru
significantli
enhanc
casefat
rate
found
women
agreement
find
show
increas
lung
damag
enhanc
neutrophil
influx
elev
level
bal
fluid
femal
mice
upon
influenza
viru
infect
report
discuss
possibl
sex
bia
sever
sarscov
infect
also
infect
sexrel
differ
wellestablish
result
underscor
import
issu
sex
bia
scientif
research
clinic
trail
vaccin
studi
previous
rais
other
particularli
block
antibodi
current
enter
clinic
trial
cancer
treatment
data
point
possibl
patholog
outcom
eg
influenza
viru
infect
women
result
block
therapi
wildtyp
mice
mice
made
maintain
full
background
bred
specifi
pathogen
free
spf
unit
utrecht
univers
central
anim
laboratori
use
week
age
mice
inject
intraperiton
tcid
mhv
strain
express
firefli
luciferas
fl
report
gene
mhveflm
ml
pb
intranas
infect
tcid
influenza
strain
perform
describ
mice
monitor
everi
hour
symptom
ill
addit
experi
inject
mice
intraperiton
agonist
imiquimod
invivogen
mg
ml
pb
utrecht
univers
ethic
committe
anim
experiment
approv
anim
studi
protocol
accord
advic
central
committe
anim
experiment
januari
dutch
law
anim
experiment
art
mhveflm
inject
day
mice
imag
day
day
describ
previous
minor
modif
briefli
mice
anaesthet
isofluran
subsequ
inject
ml
fl
substrat
dluciferin
synchem
figur
stimul
directli
inhibit
tlr
mediat
nfkb
activ
hek
cell
transient
transfect
nfkb
luciferas
report
chimera
signalingdefect
construct
twentyfour
hour
later
cell
stimul
control
antibodi
fortyeight
hour
transfect
cell
stimul
ligand
imiquimod
mgml
seventytwo
hour
transfect
cell
harvest
luciferas
activ
total
protein
content
determin
protein
normal
luciferas
activ
independ
experi
shown
b
hek
cell
stabl
express
transient
transfect
nfkb
luciferas
report
construct
ifnb
luciferas
report
construct
chimera
stimul
crosslink
perform
protein
normal
luciferas
activ
independ
experi
shown
mean
sem
shown
statist
signific
calcul
mannwhitney
test
ns
signific
laborgemeinschaft
ohg
dissolv
pb
mgkg
mice
posit
ventral
side
special
design
box
place
onto
stage
insid
lighttight
photon
imag
biospac
laboratori
five
mice
imag
simultan
exactli
min
inject
dluciferin
bioluminesc
signal
acquir
photovis
softwar
biospac
laboratori
interv
express
integr
light
intens
photonsmin
lowintens
visibl
light
imag
gener
use
creat
overlay
heatmap
imag
individu
anim
tissu
homogen
isol
total
rna
whole
liver
left
lung
dissect
mice
tissu
process
lyse
matrix
tube
mp
biomed
contain
ml
pb
use
fastprep
instrument
mp
biomed
tissu
homogen
g
sec
immedi
place
ice
subsequ
homogen
centrifug
g
minut
supernat
harvest
store
total
rna
isol
homogen
use
trizol
reagent
invitrogen
accord
manufactur
instruct
gene
express
level
ifna
measur
quantit
pcr
use
lightcycl
rna
master
hydrolysi
probe
combin
lightcycl
system
roch
appli
scienc
accord
manufactur
instruct
housekeep
gene
gapdh
use
refer
experi
express
gene
found
rel
constant
among
sampl
amount
mhv
rna
determin
quantit
rtpcr
use
primer
probe
direct
n
gene
influenza
rna
quantif
primer
map
influenza
nucleoprotein
n
gene
use
amplif
detect
perform
abi
prism
system
sampl
control
presenc
possibl
inhibitor
amplif
reaction
intern
control
murin
encephalomyocard
viru
dna
bronchoalveolar
lavag
bal
fluid
obtain
flush
lung
two
time
ml
pb
use
canula
insert
trachea
yield
around
ml
bal
fluid
pellet
cell
bal
fluid
count
cytospin
prepar
stain
maygrunwaldgiemsa
neutrophil
score
basi
morpholog
dade
behr
switzerland
bal
fluid
kept
ice
store
process
bal
fluid
centrifug
ml
aliquot
use
determin
protein
concentr
bca
kit
pierc
accord
manufactur
instruct
measur
interferon
concentr
sera
blood
sampl
mice
four
day
mhv
infect
one
hour
imiquimod
treatment
sera
separ
spin
blood
g
liver
mhvinfect
mice
sampl
fix
neutral
buffer
formalin
embed
paraffin
seven
mm
liver
section
stain
hematoxylin
eosin
total
liver
section
examin
light
microscopi
foci
hepatocellular
necrosi
inflamm
score
semiquantit
manner
hek
cell
transient
cotransfect
human
kindli
provid
rogier
sander
amc
amsterdam
netherland
nfkbreport
ifnareport
construct
kindli
provid
dr
paul
moynagh
nation
univers
ireland
chimer
construct
contain
extra
cellular
region
human
amino
acid
fuse
transmembran
intracellular
rat
amino
acid
clone
invitrogen
breda
netherland
tyrosin
phenylalanin
f
mutant
tyrosin
intracellular
tail
gener
pcrbase
mutagenesi
mutant
clone
vector
sequenc
confirm
autom
dna
sequenc
plasmid
cotransfect
report
construct
twentyfour
hour
transfect
cell
trypsin
seed
plate
coat
ugml
monoclon
antibodi
clone
fortyeight
hr
transfect
cell
stimul
imiquimod
mgml
invivogen
pb
next
day
cell
lyse
passiv
lysi
buffer
promega
luciferas
activ
measur
luminomet
berthold
technolog
centro
lb
data
analyz
microwin
softwar
total
protein
content
determin
pierc
bca
protein
assay
thermo
scientif
luciferas
valu
normal
protein
concentr
altern
use
hek
cell
stabli
express
human
invivogen
signific
calcul
mannwhitney
test
use
graphpad
prism
softwar
onlin
supplement
materi
figur
show
bli
measur
mice
viral
spread
mhv
day
infect
figur
depict
quantif
lung
patholog
differenti
cell
count
bal
fluid
influenza
viru
infect
mice
figur
quantit
analysi
mrna
male
femal
mice
nuclear
lung
surfac
area
use
benchmark
inflammatori
respons
color
rang
select
measur
thrice
rel
nuclear
surfac
area
nuclear
surfac
arealung
surfac
area
lung
section
use
measur
tissu
respons
exposur
influenza
viru
b
total
cell
count
bal
fluid
quantif
monocyt
c
lymphocyt
number
bal
fluid
differenti
cell
count
panel
mean
sem
shown
statist
signific
calcul
mannwhitney
test
doc
figur
sex
differ
express
mrna
four
day
mhv
inject
mice
sacrif
rna
isol
liver
mrna
express
quantifi
qpcr
male
femal
wt
mice
mean
sem
shown
doc
